WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Study to Find the Dose of Rapidly Administered Ketamine for Brief Painful Procedures in Children
- First Posted Date
- 2012-08-21
- Last Posted Date
- 2019-04-25
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 111
- Registration Number
- NCT01669642
- Locations
- 🇺🇸
St Louis Children's hospital, Washington university, Saint Louis, Missouri, United States
Efavirenz and Ritonavir on Human Brain P-Glycoprotein
Phase 1
Completed
- Conditions
- Drug Effects
- Interventions
- Drug: [11C] desmethyl-loperamideOther: Control - no pretreatmentDrug: Oral ritonavirDrug: Oral efavirenz
- First Posted Date
- 2012-08-17
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT01668147
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
Phase 1
Completed
- Conditions
- Carcinoma, HepatocellularIntrahepatic Cholangiocarcinoma
- Interventions
- Radiation: Stereotactic radiation
- First Posted Date
- 2012-08-17
- Last Posted Date
- 2017-02-20
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 28
- Registration Number
- NCT01668134
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
Phase 1
Completed
- Conditions
- Wilms TumorOsteosarcomaNeuroectodermal Tumors, PrimitiveSarcoma, EwingRhabdomyosarcomaRetinoblastomaGlioma
- Interventions
- First Posted Date
- 2012-08-09
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 14
- Registration Number
- NCT01661400
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Vitamin D, Cardiovascular Disease, and African Americans
Not Applicable
Completed
- Conditions
- Type 2 Diabetes MellitusVitamin D DeficiencyCardiovascular Disease
- Interventions
- Dietary Supplement: Vitamin D3Dietary Supplement: Calcium carbonate
- First Posted Date
- 2012-08-02
- Last Posted Date
- 2020-06-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 86
- Registration Number
- NCT01655810
- Locations
- 🇺🇸
Washington University, Saint Louis, Missouri, United States
Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation
Phase 2
Terminated
- Conditions
- Multiple Myeloma
- Interventions
- Drug: BortezomibDrug: CarmustineDrug: EtoposideDrug: CytarabineDrug: MelphalanProcedure: Stem cell infusion
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT01653418
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
Fatty Acid Radiotracer Comparison Study in Heart Failure Patients
Early Phase 1
Completed
- Conditions
- ObesityHeart FailureType 2 Diabetes MellitusHealth Normal Volunteer Subjects
- Interventions
- Drug: [18F]FluorbetaOx
- First Posted Date
- 2012-07-24
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT01648296
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
CYP2B6 Polymorphisms in Methadone Disposition
Not Applicable
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: IV racemic methadone HClDrug: Oral racemic methadone HCl
- First Posted Date
- 2012-07-24
- Last Posted Date
- 2018-06-20
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 78
- Registration Number
- NCT01648283
- Locations
- 🇺🇸
Washington University Schoool of Medicine, Saint Louis, Missouri, United States
Buprenorphine Disposition and Cyclosporine
- First Posted Date
- 2012-07-24
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 25
- Registration Number
- NCT01648270
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Resistance Exercise in Barth Syndrome
Not Applicable
Completed
- Conditions
- Barth Syndrome
- Interventions
- Behavioral: Resistance exercise and protein supplementation
- First Posted Date
- 2012-06-27
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT01629459
- Locations
- 🇺🇸
Washington University, Saint Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath